| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 DRD3 HIVEP2 MED14 AKNA ETV5 POU1F1 RELA SKI SIRT1 TFDP1 TFE3 KMT2C HOXB3 TAF3 NFATC4 SPZ1 BRD4 CD40 AATF PAX7 FUBP3 NOTCH1 SMAD4 SMAD5 ZNF574 NOBOX | 2.87e-07 | 1390 | 135 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SEMA6C ARHGAP32 AKAP5 ATP7A NUMBL FAT3 PLEKHM1 SIRT1 TBC1D17 SCARF1 PTPN9 NEO1 TRIM67 FIG4 NFATC4 TBC1D1 CDC20 | 3.87e-05 | 846 | 135 | 17 | GO:0120035 |
| GeneOntologyBiologicalProcess | pattern specification process | SHROOM3 IFT172 SKI HOXB3 DCANP1 POFUT1 PAX7 EMX2 NOTCH1 SMAD4 SMAD5 CCDC40 DNAH11 | 4.28e-05 | 526 | 135 | 13 | GO:0007389 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | SEMA6C ARHGAP32 AKAP5 ATP7A NUMBL FAT3 PLEKHM1 SIRT1 TBC1D17 SCARF1 PTPN9 NEO1 TRIM67 FIG4 NFATC4 TBC1D1 CDC20 | 4.96e-05 | 863 | 135 | 17 | GO:0031344 |
| GeneOntologyCellularComponent | transcription regulator complex | TRERF1 HIVEP2 MED14 POU1F1 RELA CHD4 SKI BATF2 TFDP1 TFE3 TAF3 GTF3C2 NFATC4 AATF MMS19 PAX7 SMAD4 SMAD5 NOBOX | 1.63e-08 | 596 | 139 | 19 | GO:0005667 |
| Domain | VCX_VCY | 1.22e-08 | 5 | 133 | 4 | PF15231 | |
| Domain | VCX/VCY1 | 1.22e-08 | 5 | 133 | 4 | IPR026653 | |
| Domain | DUF4599 | 1.29e-08 | 12 | 133 | 5 | PF15371 | |
| Domain | DUF4599 | 1.29e-08 | 12 | 133 | 5 | IPR027970 | |
| Domain | Shroom_fam | 2.99e-04 | 4 | 133 | 2 | IPR027685 | |
| Domain | ASD2_dom | 2.99e-04 | 4 | 133 | 2 | IPR014799 | |
| Domain | ASD2 | 2.99e-04 | 4 | 133 | 2 | PF08687 | |
| Domain | ASD2 | 2.99e-04 | 4 | 133 | 2 | PS51307 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C SHROOM3 HIVEP2 MAN2B1 SH2B3 MED14 AKNA MED13L NPHP4 AHDC1 PLEKHM1 TBC1D17 TFE3 RHPN1 KMT2C FAT1 TRAPPC12 RALGPS1 BRD4 PXN POFUT1 NOTCH1 CYB5R2 | 9.27e-11 | 1105 | 139 | 23 | 35748872 |
| Pubmed | 2.44e-10 | 4 | 139 | 4 | 10903929 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 TSHZ3 HIVEP2 AKNA POU1F1 RELA SKI BATF2 SOX13 ZBTB24 TFDP1 TFE3 HOXB3 NFATC4 PROX2 PAX7 EMX2 SMAD4 SMAD5 NOBOX | 6.71e-10 | 908 | 139 | 20 | 19274049 |
| Pubmed | 1.22e-09 | 5 | 139 | 4 | 10607842 | ||
| Pubmed | 3.64e-09 | 6 | 139 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 3.64e-09 | 6 | 139 | 4 | 25930072 | |
| Pubmed | 3.79e-08 | 24 | 139 | 5 | 32212159 | ||
| Pubmed | 3.91e-08 | 48 | 139 | 6 | 27703004 | ||
| Pubmed | TRERF1 ARHGAP32 TSHZ3 ETV5 RELA SKI SOX13 SIRT1 TFDP1 TFE3 DAP3 KMT2C FAT1 TAF3 GTF3C2 NFATC4 SPZ1 OTUD4 N4BP1 PAX7 FUBP3 SMAD5 | 5.86e-08 | 1429 | 139 | 22 | 35140242 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 18076704 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | HIVEP2 TRIM25 PAPOLB RELA CHD4 SKI ZBTB24 SIRT1 TFDP1 NFATC4 SPZ1 AATF MMS19 EMX2 FUBP3 SMAD4 SMAD5 | 8.94e-08 | 877 | 139 | 17 | 20211142 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 TSHZ3 HIVEP2 MSH3 SKI SOX13 AHDC1 SIRT1 TFDP1 KMT2C TAF3 | 1.87e-07 | 351 | 139 | 11 | 38297188 |
| Pubmed | Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. | 6.21e-07 | 5 | 139 | 3 | 11121043 | |
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 17342728 | ||
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 2.16e-06 | 7 | 139 | 3 | 14699069 | |
| Pubmed | HIVEP2 ETV5 CHD4 SOX13 TFDP1 TFE3 KMT2C NFATC4 BRD4 PROX2 PXN PAX7 EMX2 | 5.84e-06 | 709 | 139 | 13 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TSHZ3 BAZ2B ARHGEF5 CHD4 MSH3 ZBTB24 SIRT1 TFDP1 DAP3 TAF3 GTF3C2 BRD4 | 6.50e-06 | 608 | 139 | 12 | 36089195 |
| Pubmed | A genome-wide association study identifies three new risk loci for Kawasaki disease. | 7.34e-06 | 10 | 139 | 3 | 22446962 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 ARHGAP32 TSHZ3 SHROOM3 TRIM25 SPATA31E1 ARHGEF5 NFATC4 PAX7 NOTCH1 | 9.71e-06 | 430 | 139 | 10 | 35044719 |
| Pubmed | ARHGAP32 WDR64 IDE TFE3 DAP3 PTPN9 PIGT TRAPPC12 OTUD4 AATF FER1L5 DNAH11 | 1.05e-05 | 638 | 139 | 12 | 31182584 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22330808 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25107841 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27855784 | ||
| Pubmed | Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer. | 1.59e-05 | 2 | 139 | 2 | 25420528 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17041012 | ||
| Pubmed | Modulation of neuritogenesis by a protein implicated in X-linked mental retardation. | 1.59e-05 | 2 | 139 | 2 | 19812318 | |
| Pubmed | Endothelial dysfunction is a superinducer of syndecan-4: fibrogenic role of its ectodomain. | 1.59e-05 | 2 | 139 | 2 | 29101181 | |
| Pubmed | The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. | 1.59e-05 | 2 | 139 | 2 | 27007123 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28334865 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18800364 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24928394 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31115487 | ||
| Pubmed | Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA. | 1.59e-05 | 2 | 139 | 2 | 11268217 | |
| Pubmed | Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. | 1.59e-05 | 2 | 139 | 2 | 16249884 | |
| Pubmed | NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma. | 1.59e-05 | 2 | 139 | 2 | 31992226 | |
| Pubmed | Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA. | 1.59e-05 | 2 | 139 | 2 | 23686307 | |
| Pubmed | Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. | 1.59e-05 | 2 | 139 | 2 | 15152190 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25257945 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28295567 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21771876 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12862317 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35166167 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20346213 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29784872 | ||
| Pubmed | Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. | 1.59e-05 | 2 | 139 | 2 | 21799861 | |
| Pubmed | FOXO3 Activation Prevents Cellular Senescence in Emphysema Induced by Cigarette Smoke. | 1.59e-05 | 2 | 139 | 2 | 36656684 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27798157 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18347015 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37200907 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24067439 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20617556 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23178899 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28600541 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33411691 | ||
| Pubmed | NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. | 1.59e-05 | 2 | 139 | 2 | 25263595 | |
| Pubmed | SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway. | 1.59e-05 | 2 | 139 | 2 | 22717288 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24970476 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22645123 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38976017 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25600643 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23103739 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10636910 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28709865 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27524235 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NUMBL RELA SOX13 ARAF SYDE1 TBC1D17 TFE3 C5orf34 DBF4 PXN OTUD4 AATF CDC20 SMAD4 SMAD5 | 1.87e-05 | 1038 | 139 | 15 | 26673895 |
| Pubmed | Inhibition of Notch2 by Numb/Numblike controls myocardial compaction in the heart. | 2.20e-05 | 14 | 139 | 3 | 22865640 | |
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 2.20e-05 | 14 | 139 | 3 | 33248111 | |
| Pubmed | DENND5B RNPC3 SYDE1 TFDP1 DAP3 KMT2C FAT1 TRAPPC12 TBC1D1 MMS19 SMAD4 DNAH11 | 2.24e-05 | 689 | 139 | 12 | 36543142 | |
| Pubmed | TRERF1 ETV5 RELA SOX13 ZBTB24 TFDP1 TFE3 DBF4 BRD4 PXN AATF SMAD4 NOBOX | 2.31e-05 | 808 | 139 | 13 | 20412781 | |
| Pubmed | ARHGAP32 BAZ2B RNPC3 NPHP4 SHROOM4 CMIP FIG4 N4BP1 REXO1L1P PALLD | 3.12e-05 | 493 | 139 | 10 | 15368895 | |
| Pubmed | 4.46e-05 | 233 | 139 | 7 | 37704626 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 12857746 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29095923 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29139178 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 4.75e-05 | 3 | 139 | 2 | 15744052 | |
| Pubmed | Syndecan-3 and Notch cooperate in regulating adult myogenesis. | 4.75e-05 | 3 | 139 | 2 | 20696709 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26503358 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26977879 | ||
| Pubmed | NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice. | 4.75e-05 | 3 | 139 | 2 | 27127236 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 30300821 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 22351752 | ||
| Pubmed | The Notch regulator Numb links the Notch and TCR signaling pathways. | 4.75e-05 | 3 | 139 | 2 | 15634911 | |
| Pubmed | Testis-enriched ferlin, FER1L5, is required for Ca2+-activated acrosome reaction and male fertility. | 4.75e-05 | 3 | 139 | 2 | 36696506 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 10557285 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29463681 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 28077651 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26339396 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 8642313 | ||
| Pubmed | Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. | 4.75e-05 | 3 | 139 | 2 | 16885355 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 23603572 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29049420 | ||
| Pubmed | C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity. | 4.75e-05 | 3 | 139 | 2 | 19019440 | |
| Pubmed | Are Ski and SnoN Involved in the Tumorigenesis of Oral Squamous Cell Carcinoma Through Smad4? | 4.75e-05 | 3 | 139 | 2 | 29734252 | |
| Pubmed | A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. | 4.75e-05 | 3 | 139 | 2 | 10675325 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29663368 | ||
| Pubmed | B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation. | 4.75e-05 | 3 | 139 | 2 | 16393971 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 32991757 | ||
| Pubmed | Satellite cell-specific deletion of Cipc alleviates myopathy in mdx mice. | 4.75e-05 | 3 | 139 | 2 | 35705041 | |
| Pubmed | Molecular mechanisms of syndecan-4 upregulation by TNF-α in the endothelium-like EAhy926 cells. | 4.75e-05 | 3 | 139 | 2 | 23576453 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29856490 | ||
| Interaction | TOP3B interactions | SEMA6C SHROOM3 HIVEP2 TRIM25 MAN2B1 SH2B3 MED14 AKNA IREB2 MSH3 MED13L NPHP4 AHDC1 PLEKHM1 TBC1D17 TFE3 RHPN1 KMT2C FAT1 TRAPPC12 RALGPS1 BRD4 PXN OTUD4 MMS19 POFUT1 FUBP3 NOTCH1 CYB5R2 | 1.11e-07 | 1470 | 135 | 29 | int:TOP3B |
| Interaction | DCANP1 interactions | 6.90e-06 | 19 | 135 | 4 | int:DCANP1 | |
| Interaction | AR interactions | TRERF1 TRIM25 MED14 ETV5 RELA CHD4 IDE MED13L SKI AHDC1 SIRT1 BLK DAP3 KMT2C BRD4 PXN AATF MMS19 FUBP3 SMAD4 | 1.00e-05 | 992 | 135 | 20 | int:AR |
| Interaction | ZMIZ1 interactions | 1.10e-05 | 44 | 135 | 5 | int:ZMIZ1 | |
| Interaction | SMAD2 interactions | RNPC3 IRAK2 RELA SKI KMT2C TAF3 TRIM67 GTF3C2 TBC1D1 HSD17B3 SMAD4 SMAD5 | 1.12e-05 | 385 | 135 | 12 | int:SMAD2 |
| Interaction | DNASE2 interactions | 2.57e-05 | 26 | 135 | 4 | int:DNASE2 | |
| Interaction | KAT2A interactions | 2.93e-05 | 180 | 135 | 8 | int:KAT2A | |
| GeneFamily | Variable charge X/Y family | 2.94e-11 | 6 | 101 | 5 | 368 | |
| GeneFamily | Ferlin family | 4.57e-04 | 6 | 101 | 2 | 828 | |
| GeneFamily | SMAD family | 8.46e-04 | 8 | 101 | 2 | 750 | |
| GeneFamily | PHD finger proteins | 1.62e-03 | 90 | 101 | 4 | 88 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | HIVEP2 SH2B3 BAZ2B MED13L AHDC1 ZBTB24 FAT1 OTUD4 N4BP1 SMAD5 | 4.52e-06 | 300 | 138 | 10 | M8702 |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP | 1.01e-05 | 141 | 138 | 7 | M466 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.06e-05 | 198 | 138 | 8 | M7948 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.72e-06 | 195 | 139 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.72e-06 | 195 | 139 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.72e-06 | 195 | 139 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-06 | 197 | 139 | 7 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-06 | 197 | 139 | 7 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 157 | 139 | 6 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 1.53e-05 | 169 | 139 | 6 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-05 | 170 | 139 | 6 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 172 | 139 | 6 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 172 | 139 | 6 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 172 | 139 | 6 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-05 | 175 | 139 | 6 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.05e-05 | 178 | 139 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.39e-05 | 183 | 139 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 185 | 139 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 187 | 139 | 6 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.78e-05 | 188 | 139 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 2.78e-05 | 188 | 139 | 6 | 0e8ac42c439f30a05e015210e1d5c2dcb9d9d471 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 190 | 139 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.95e-05 | 190 | 139 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.06e-05 | 115 | 139 | 5 | c724e8b1fddcefdaa8d247aaff68c986538068f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.22e-05 | 193 | 139 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.22e-05 | 193 | 139 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 3.22e-05 | 193 | 139 | 6 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 139 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 197 | 139 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 199 | 139 | 6 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 199 | 139 | 6 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 125 | 139 | 5 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 148 | 139 | 5 | 6ffa212f0cc44c40d2143816dc6cfd82fbf09a33 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.12e-04 | 151 | 139 | 5 | 88f7498f29e43441e0982f9f97ea563edf2835a4 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 1.30e-04 | 156 | 139 | 5 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 1.46e-04 | 160 | 139 | 5 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 1.60e-04 | 163 | 139 | 5 | 4eac7fd8acdb7f09ce739335f22a879f9b8febfb | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 163 | 139 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 163 | 139 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 164 | 139 | 5 | 69b6566fb88c7449b7ab9056b57508cb6a1aa2af | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.74e-04 | 166 | 139 | 5 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.84e-04 | 168 | 139 | 5 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.84e-04 | 168 | 139 | 5 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-04 | 170 | 139 | 5 | 4b1c84b35b7242a297ffdb9c23a6d982acf1bed5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 171 | 139 | 5 | b6ee3a6bc436df5e9129b8e0bed9fa3078a4ff23 | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 1.99e-04 | 171 | 139 | 5 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 172 | 139 | 5 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 172 | 139 | 5 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 172 | 139 | 5 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 2.05e-04 | 172 | 139 | 5 | 36f2444754f1e37683cb812380e6b05b356f9f4a | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 172 | 139 | 5 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-04 | 173 | 139 | 5 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-04 | 173 | 139 | 5 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-04 | 173 | 139 | 5 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-04 | 173 | 139 | 5 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-04 | 173 | 139 | 5 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-04 | 173 | 139 | 5 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 174 | 139 | 5 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 174 | 139 | 5 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 174 | 139 | 5 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 176 | 139 | 5 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.34e-04 | 177 | 139 | 5 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 2.34e-04 | 177 | 139 | 5 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-04 | 177 | 139 | 5 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-04 | 177 | 139 | 5 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|World / disease group, cell group and cell class (v2) | 2.34e-04 | 177 | 139 | 5 | 057871e211c6508b2a679d391f3cf0ac7ccfc628 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-04 | 177 | 139 | 5 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-04 | 177 | 139 | 5 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-04 | 178 | 139 | 5 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.40e-04 | 178 | 139 | 5 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 180 | 139 | 5 | 243622eee35d38748e945677ff115616e763e3b4 | |
| ToppCell | Severe-Lymphoid-B|Severe / Condition, Lineage, Cell class and cell subclass | 2.53e-04 | 180 | 139 | 5 | 67ffaf5096f025c3c61fffe52f6c8a96f120fc6f | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 180 | 139 | 5 | 3a8d9a71efe113d1df3933902a625c0a56812074 | |
| ToppCell | Severe-Lymphoid-B-|Severe / Condition, Lineage, Cell class and cell subclass | 2.53e-04 | 180 | 139 | 5 | fd3eb751704b14ff1500e4bd041441644d233e9c | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 181 | 139 | 5 | 2a3092fbadd18967199f1203c11f0dd956417254 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-04 | 181 | 139 | 5 | 6df40f86c569b6ecfc3137a68d1355b012dbf6bf | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.59e-04 | 181 | 139 | 5 | 768d14c452192f92fa557ae59e84c43436f575f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-04 | 181 | 139 | 5 | 0c52dd82e6b3dce3d6bb5c13501bf8383f7121e4 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 182 | 139 | 5 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-04 | 182 | 139 | 5 | ccd729388d997cc45071175cb0c3db6d0790eaf8 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 183 | 139 | 5 | 0513bb73552bfee609877d924fa97684200f595c | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 183 | 139 | 5 | 6eeef55071ae25a61616df4fcfb2cea560aa7923 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 183 | 139 | 5 | 85b2335fa938a94e74251bd8d99de1bd21265ac9 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 185 | 139 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 185 | 139 | 5 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 185 | 139 | 5 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 185 | 139 | 5 | a92bd84e44fc992b7eeefaa2ff8091ed09f0df00 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 185 | 139 | 5 | 877eb127ac797f8a1e1a9e0049fa16cae16cfa35 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-04 | 186 | 139 | 5 | f352c63666273defea3e57ba3a3bfad52c4ea65b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-04 | 186 | 139 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.94e-04 | 186 | 139 | 5 | e2d265003aaea1acaf618d3f102c9933c19102e6 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-04 | 186 | 139 | 5 | b5e094850ac3785775393cd78a939b02339732b0 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 186 | 139 | 5 | 664295cd508dc3894d55da7e9d9cd75bf1432f52 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-04 | 186 | 139 | 5 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | moderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-04 | 186 | 139 | 5 | fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 186 | 139 | 5 | b30eb0c1673ca1ebc9b6248877d86fd6d6d14470 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-04 | 186 | 139 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 2.94e-04 | 186 | 139 | 5 | 9d339f57036d17572882ebb801f2be9b1d1ddc1c | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.35e-06 | 57 | 130 | 5 | DOID:10652 (implicated_via_orthology) | |
| Disease | Pituitary dwarfism | 1.93e-05 | 2 | 130 | 2 | C0013338 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.31e-05 | 13 | 130 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Colonic Neoplasms | 5.97e-05 | 152 | 130 | 6 | C0009375 | |
| Disease | Malignant tumor of colon | 7.66e-05 | 159 | 130 | 6 | C0007102 | |
| Disease | Mucocutaneous Lymph Node Syndrome | 1.15e-04 | 4 | 130 | 2 | C0026691 | |
| Disease | bacterial infectious disease (implicated_via_orthology) | 1.91e-04 | 5 | 130 | 2 | DOID:104 (implicated_via_orthology) | |
| Disease | brain cancer (implicated_via_orthology) | 2.02e-04 | 26 | 130 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | lymphoma (is_implicated_in) | 2.86e-04 | 6 | 130 | 2 | DOID:0060058 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 3.93e-04 | 215 | 130 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | panhypopituitarism (is_implicated_in) | 3.99e-04 | 7 | 130 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 3.99e-04 | 7 | 130 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Acute lymphocytic leukemia | 3.99e-04 | 7 | 130 | 2 | C0023449 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 3.99e-04 | 7 | 130 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | Scoliosis, unspecified | 5.30e-04 | 8 | 130 | 2 | C0036439 | |
| Disease | Nephronophthisis | 6.80e-04 | 9 | 130 | 2 | cv:C0687120 | |
| Disease | Todd Paralysis | 6.80e-04 | 9 | 130 | 2 | C0234544 | |
| Disease | Liver Diseases, Parasitic | 6.80e-04 | 9 | 130 | 2 | C0023897 | |
| Disease | Paralysed | 6.80e-04 | 9 | 130 | 2 | C0522224 | |
| Disease | Pancreatic carcinoma, familial | 6.80e-04 | 9 | 130 | 2 | C2931038 | |
| Disease | Squamous cell carcinoma of esophagus | 8.40e-04 | 95 | 130 | 4 | C0279626 | |
| Disease | inflammatory bowel disease | 8.71e-04 | 449 | 130 | 8 | EFO_0003767 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.04e-03 | 45 | 130 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | ovarian serous carcinoma | 1.10e-03 | 46 | 130 | 3 | EFO_1001516 | |
| Disease | pneumonia | 1.18e-03 | 47 | 130 | 3 | EFO_0003106 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.24e-03 | 12 | 130 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | diffuse large B-cell lymphoma (is_implicated_in) | 1.24e-03 | 12 | 130 | 2 | DOID:0050745 (is_implicated_in) | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 1.46e-03 | 13 | 130 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.67e-03 | 53 | 130 | 3 | C4707243 | |
| Disease | Schizophrenia | IL10RA ARHGAP32 DRD3 NUMBL RELA CHD4 IDE SIRT1 MAGEC1 EMX2 SMAD5 | 1.86e-03 | 883 | 130 | 11 | C0036341 |
| Disease | colorectal cancer (is_implicated_in) | 2.05e-03 | 121 | 130 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Blood Coagulation Disorders | 2.22e-03 | 16 | 130 | 2 | C0005779 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.22e-03 | 16 | 130 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.22e-03 | 16 | 130 | 2 | C2713443 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.50e-03 | 61 | 130 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Amyotrophic lateral sclerosis | 2.51e-03 | 17 | 130 | 2 | cv:C0002736 | |
| Disease | Adenomatous Polyposis Coli | 2.51e-03 | 17 | 130 | 2 | C0032580 | |
| Disease | forced expiratory volume | TSHZ3 IREB2 SKI ZBTB24 PLEKHM1 HOXB3 FIG4 NFATC4 OTUD4 POFUT1 | 2.64e-03 | 789 | 130 | 10 | EFO_0004314 |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.74e-03 | 63 | 130 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | noggin measurement | 2.81e-03 | 18 | 130 | 2 | EFO_0021995 | |
| Disease | ovulation | 3.14e-03 | 19 | 130 | 2 | GO_0030728 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.39e-03 | 139 | 130 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | colorectal adenoma (is_marker_for) | 3.47e-03 | 20 | 130 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | atherosclerosis (biomarker_via_orthology) | 3.47e-03 | 20 | 130 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | chronic obstructive pulmonary disease | 3.50e-03 | 688 | 130 | 9 | EFO_0000341 | |
| Disease | epilepsy (biomarker_via_orthology) | 3.83e-03 | 21 | 130 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | pentachlorophenol measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 4.15e-03 | 73 | 130 | 3 | EFO_0008360 | |
| Disease | Bronchiectasis | 4.20e-03 | 22 | 130 | 2 | C0006267 | |
| Disease | DDT metabolite measurement | 4.31e-03 | 74 | 130 | 3 | EFO_0007886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HSPAPPENFGNELLP | 41 | Q8TF63 | |
| HSLLQLDAPIPNAPP | 11 | Q12834 | |
| TPHPFPAVTPDLIVQ | 221 | O60885 | |
| APQLEFEQLPFSHPL | 271 | Q86V21 | |
| QPLLEEAIPNLHSPP | 371 | Q96Q42 | |
| AAPPQPPHIIFILTD | 41 | Q5FYB1 | |
| IPPLFAPPAQNHDSS | 136 | Q9UIF8 | |
| PPEELQESQGLLHPQ | 211 | Q12774 | |
| IVAIAPLLENNHPPP | 226 | Q8IY22 | |
| PLLENNHPPPDLCEF | 231 | Q8IY22 | |
| PTPDEHIIPQGLLEN | 4026 | Q96DT5 | |
| PFQPVVLLHIRDVPP | 21 | Q13362 | |
| EPLEIVFSHQRPPPN | 196 | Q86Y34 | |
| PPLAHPPTVFDAGLQ | 1381 | Q5TGY3 | |
| QAKAPFHTPPEEPNE | 546 | Q9UBU7 | |
| FDAVIHNPDPLPVLT | 71 | Q04656 | |
| DAAPAQVAVFLPPPH | 471 | Q9Y6R0 | |
| PQKTLPDHAVPAAFP | 216 | Q5JR59 | |
| PPPLIQTAAHPNLEK | 251 | Q6BCY4 | |
| NPAPLLVSPEVHLTP | 571 | Q01804 | |
| PDDPEHPDIFQLNNP | 501 | Q5JS13 | |
| NTPILCPFHLQPVPE | 196 | P48200 | |
| CPFHLQPVPEPETVL | 201 | P48200 | |
| LPQVNGHPDPFDEII | 251 | P43378 | |
| ADLPFPLGPVHTPQL | 451 | O60393 | |
| VPPQPQADFSISPLH | 396 | P23759 | |
| PFHPFPALPENEDTQ | 601 | Q06481 | |
| HVNPQSFPAPKENPD | 416 | Q9NRJ5 | |
| LPPEFSNQFESIHPP | 4451 | Q14517 | |
| FPPQLPPHIATEIDR | 71 | P20585 | |
| PPKNPHNPTDLFDSV | 636 | Q460N3 | |
| VQSETVEPPPPAQLH | 1721 | P46531 | |
| QLQVPEHPFLTPSPE | 2501 | P46531 | |
| QPPLTPHPAVNESFA | 2096 | Q8NEZ4 | |
| NTVACLDHLDPPQPP | 311 | Q9HCP6 | |
| QPLHFLDPLPLSQQP | 691 | Q71F56 | |
| LSPLHFPQFPPQGED | 721 | O60732 | |
| GQIPFPPASTQEPLH | 3266 | Q16787 | |
| PAFLQPPEEDAPHSL | 151 | O43187 | |
| FTPPPNDPHGIQRED | 226 | Q96T76 | |
| HLTVDLPEQPYLQPP | 991 | A9Z1Z3 | |
| IGISPEPPLVQPLHF | 66 | O14576 | |
| LPEAHAPQSPFVLAP | 651 | Q3V5L5 | |
| AHVELQRNPPPNSDP | 386 | Q96I24 | |
| EEPQFLLPDPHPQAD | 331 | Q13651 | |
| PDFQSDNLVLHAPPP | 71 | P41161 | |
| EPGLPPTFTFHVNPV | 226 | Q68DD2 | |
| HPLEFADKSPTPPNL | 1226 | A7KAX9 | |
| PSQEHLNGPLPVPFT | 246 | O14745 | |
| PHPALEPAFHLLPEN | 191 | O75161 | |
| EQLQELPFTPLHAPI | 566 | O75161 | |
| IDLQVHVPPSIAPGP | 3796 | Q96RW7 | |
| PFEVPLPAKQHVPEA | 1626 | Q9UG01 | |
| VSKPLQIFHDPPLPA | 366 | O60244 | |
| NDHFQHFPPPPPILE | 556 | Q8WX93 | |
| GNHTYQEIAVPPPVP | 36 | P49023 | |
| QDPPANFPLTAPSHI | 326 | Q3B8N5 | |
| HFPFPAPANAPLQRI | 196 | P10398 | |
| LIHSIPQFPPIPEEG | 141 | Q8WZ79 | |
| PKPPITLDQADPFAH | 341 | Q92562 | |
| APHPDQPEFTPVQDE | 1771 | Q05707 | |
| LVVFNHLTPPPPDEH | 41 | P51451 | |
| AQTAPPQPLELEHPT | 201 | Q8N1L9 | |
| QPPPAKLLPEHAQTL | 281 | P23610 | |
| VSQEPVIPPGVPDAH | 221 | Q4G0X9 | |
| PPPHEEEFLSQDQLP | 4406 | Q8TDW7 | |
| VPPQPPFQAATHLEG | 31 | P14651 | |
| AALEAPEFPLPSHQP | 116 | Q8IX06 | |
| TSQQPPPLPLESYIH | 216 | Q6ZUT9 | |
| DHQQPVLSDVPPLPA | 256 | P24588 | |
| PPAHPITRVPQEFQT | 421 | Q7Z591 | |
| PTPHQTPYQLDPANI | 976 | O00754 | |
| GPSPHFLQQPEDLVV | 21 | Q6UWL6 | |
| KNVPLPEFPEHPFQE | 281 | P14735 | |
| SQPLNLAHVPGEEPP | 226 | Q9BSE4 | |
| FAEAVSHPPNPAVPV | 71 | Q04743 | |
| HGAASPQLEPEPQIP | 136 | Q9NT22 | |
| DALLNNSLPPPHPEN | 21 | Q14839 | |
| FEKSPPVSAHPLEQP | 36 | Q96MH7 | |
| PNLLPSHFLNAPDEI | 136 | P37058 | |
| PEVVHPLVPLDNHIP | 76 | P31431 | |
| VSERPFPPHIQLPPE | 136 | P20273 | |
| FPPHIQLPPEIQESQ | 141 | P20273 | |
| PGFPQQTLSPDPAHL | 236 | P35462 | |
| LPELQPQPLLPQHDS | 201 | Q8TE04 | |
| QVTYSLLPPQDPHLP | 486 | Q9UN66 | |
| EHPVLALPGAPAQFP | 186 | Q9H488 | |
| FPELDQQLQPLPPCH | 36 | P57077 | |
| IHPQFLEELLSPDPQ | 511 | Q5VT03 | |
| VHVQEPRPQAPSPLD | 371 | Q9Y4G2 | |
| SPQDLETVFPHGLPP | 71 | P51398 | |
| LQAPAPPHAAAEPDL | 431 | Q9NSD7 | |
| QPPLHLPLADPEVVT | 621 | Q6ZW31 | |
| NIEPVTFPHQIPSFP | 86 | Q5VWG9 | |
| PSDQPSQELPQHELP | 76 | Q9NNX9 | |
| PSDQPSQELPQHELP | 76 | Q9H321 | |
| PSDQPSQELPQHELP | 76 | O14598 | |
| VPPEEHYQTFPIQDP | 1121 | P12259 | |
| PTNHLSDIFPELPAP | 2041 | A0AVI2 | |
| PLEGPFPSQSDVHPL | 821 | Q14934 | |
| PLASPDPQAKHPQDL | 151 | Q5VVP1 | |
| PPIHQPLLAEDPTAA | 91 | P28069 | |
| PLASPDPQAKHPQDL | 151 | Q8IWB4 | |
| NELAFQPPISNHPAP | 306 | Q13485 | |
| FDSQPPQPVISAHPI | 1241 | Q92859 | |
| PQGQVFSIDLPEHPP | 81 | A0A1B0GU29 | |
| PSLEPHFAQVPQPSV | 471 | Q8TF72 | |
| PHEVPQILINREPLP | 456 | Q96EB6 | |
| PEEVLEQPQPLSFGH | 1176 | Q9ULL8 | |
| PPLAEIQTQAHLSPP | 516 | Q6ZUB1 | |
| EGELPTHEQVFLQPP | 371 | Q8TCX5 | |
| AATEPPPVLHLPAIQ | 66 | P12755 | |
| PEVPFNHSFIEPPSA | 501 | Q14162 | |
| LPPVLVPRHNEFNPQ | 136 | Q99717 | |
| GEPEILPQAPANAHL | 436 | Q9NY61 | |
| ISAQPQLLFLHPPVP | 121 | Q9C0C6 | |
| PPPNSVIHLPFIIVN | 251 | Q14186 | |
| HNVQEILGLAPPAEP | 586 | Q9HA65 | |
| VQTPDGEQHLPQPLL | 36 | Q6ZTA4 | |
| HQPLPVTPDSQLALP | 236 | Q9UN79 | |
| HPVLLPSDVFDQPQP | 301 | Q96LT9 | |
| PSDQPSQELPQHELP | 76 | Q9H322 | |
| ELQAQIHGLPVPPTP | 431 | P19532 | |
| QPPAPPSDALLDLHF | 491 | P19532 | |
| PPENEAPPVPFLHAQ | 341 | Q969N2 | |
| PLASPDPQAKHPQDL | 151 | Q5TZJ5 | |
| PLASPDPQAKHPQDL | 151 | Q5VU36 | |
| AAPPASPEPFAHIQA | 271 | Q8WVT3 | |
| SKFPIDHSPPQQLPF | 231 | Q6ZQQ2 | |
| LHLNDQSEPPVIGEP | 461 | Q5T4T6 | |
| DSPAFQDHPLQPPVR | 136 | Q14258 | |
| HFPAPVPESQEPALQ | 236 | Q6ZN55 | |
| HFPVGNPEILPSSLP | 181 | Q6GPH4 | |
| HLPEEPAPLSPQQAF | 576 | Q86TI0 | |
| TLSHFPIECQEPPQP | 596 | Q86TI0 | |
| PPEQIFHLVPSPEEL | 521 | Q9UQQ2 | |
| HTQAAFPQDPLPLLI | 21 | Q9H3T2 | |
| DGQPTLLPPEHVQEL | 426 | Q9H0V1 | |
| PSDQPSQELPQHELP | 76 | Q9H320 | |
| DHPPEQPFVNPLSAL | 711 | Q63HK5 | |
| DPAQHLQLTQEPGPP | 666 | O43167 | |
| TVNPTPDPHQEYLDP | 16 | Q9BXG8 | |
| FSLPHPEALLAQQPP | 511 | Q8WUA4 | |
| QPHLFPHQETIPFSP | 1186 | P31629 | |
| PPVLSHPIFDNRAPN | 176 | Q04206 | |
| APHPKQEPQEINFPD | 226 | P25942 | |
| HPGIANLPEAQPPIL | 771 | B1ANS9 | |
| DAPQASPISPHFPQD | 46 | Q96PN7 | |
| FPENGLHQQPEPLLP | 521 | O75113 |